作者

Chris Thornham

合伙人

Read More

Laurence Lieberman

合伙人

Read More

Colin McCall

合伙人

Read More
作者

Chris Thornham

合伙人

Read More

Laurence Lieberman

合伙人

Read More

Colin McCall

合伙人

Read More

2019年9月29日 |

Arbitration considerations for life science companies

In the second instalment of our life sciences disputes webinar series – we provided practical tips and advice, discussed key legislation and shared case studies on how life sciences organisations can mitigate and manage their litigation risk, including:

  • What subject-matter can be arbitrated and how arbitration may arise.
  • Typical advantages / disadvantages of arbitration versus litigation.
  • Industry–specific points for parties in the life sciences considering arbitration.
  • Arbitration proceedings rules, tribunal composition, location and choice of law.
  • Decisions, remedies, enforcement and challenges.


View the first webinar in our series: Managing cybersecurity risk from a life sciences perspective


Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

酒店与休闲

Termination, force majeure and frustration – international perspectives on the life sciences sector

2020年4月17日
QUICK READ

作者

点击此处了解更多

相关活动